Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pivotal clinical trial for the evaluation of crofelemer in cancer therapy-related diarrhea (CTD)

Trial Profile

A pivotal clinical trial for the evaluation of crofelemer in cancer therapy-related diarrhea (CTD)

Planning
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2018

At a glance

  • Drugs Crofelemer (Primary)
  • Indications Diarrhoea
  • Focus Registrational; Therapeutic Use
  • Sponsors Jaguar Health
  • Most Recent Events

    • 14 Dec 2018 New trial record
    • 06 Dec 2018 According to a Jaguar Health media release, the Company's near-term objective is to meet with FDA to discuss the anticipated protocol
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top